Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC).
Journal: Expert opinion on pharmacotherapy
Published: July 23, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 08, 2025
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape.
Journal: Translational cancer research
Published: May 15, 2025
Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC.
Journal: JTO clinical and research reports
Published: March 21, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis.
Journal: JTO clinical and research reports
Published: July 22, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.
Journal: Pharmacoepidemiology and drug safety
Published: December 21, 2023
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC.
Journal: JTO clinical and research reports
Published: December 10, 2023
Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles.
Journal: Clinical lung cancer
Published: February 24, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026